醫學新知
Update
無標題文件


首頁 > 醫學新知 > 醫學新知
Vasomotor symptoms due to natural menopause; systematic review and network meta-analysis (NMA) of treatment effects from the NICE Menopause Guideline.
2017-03-23

BJOG. 2017 Mar 9.
doi: 10.1111/1471-0528.14619. [Epub ahead of print]

Author
Sarri G1, Pedder H1, Dias S2, Guo Y1, Lumsden MA3.

Author information
1.National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent's Park, London, NW1 4RG, UK.
2.University of Bristol, School of Social and Community Medicine, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
3.University of Glasgow, Chair of the Guideline Development Group.

Abstract

BACKGROUND:

Vasomotor symptoms (VMS) are the hallmarks of menopause, occurring in approximately 75% of postmenopausal women in the UK and are severe in 25%.

OBJECTIVES:

To identify which treatments are most clinically effective for the relief of VMS for non-hysterectomized women in natural menopause.

SEARCH STRATEGY:

English publications in MEDLINE, Embase and The Cochrane Library up to 13th January 2015 were searched.

SELECTION CRITERIA:

Randomized trials (RCTs) of treatments for women with a uterus for the outcomes of frequency of VMS (up to 26 weeks), vaginal bleeding and discontinuation.

DATA COLLECTION AND ANALYSIS:

Bayesian network meta-analysis (NMA) using mean ratios (MRs) and odd ratios (ORs).

MAIN RESULTS:

Across the three networks, 47 RCTs of 16 treatment classes (N=8326 women) were included. When compared to placebo, transdermal oestradiol and progestogen (O+P) had the highest probability of being the most effective treatment for VMS relief (69.8%) (MR: 0.23 [95%CrI (0.09, 0.57)] whereas oral O+P was ranked lower than transdermal O+P, although oral and transdermal O+P were no different for this outcome (MR: 2.23 [95%CrI (0.7, 7.1)]. Isoflavones and black cohosh were more effective than placebo, though not significantly better than O+P. Not only were SSRIs or SNRIs found ineffective in relieving VMS but they also had significantly higher odds of discontinuation than placebo. Limited data were available for bleeding therefore no conclusions could be made.

CONCLUSIONS:

For non-hysterectomized women, transdermal O+P was the most effective treatment for VMS relief.

資料來源 : PubMed



瀏覽次數: 686

Untitled Document